Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice

Diabetes, Obesity and Metabolism

Volumn 7, Issue 4, 2005, Pages 360-369

  Liang, Yin ^a   Chen, X ^a   Osborne, M ^a   DeCarlo, S O ^a   Jetton, T L ^b   Demarest, K ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

OGTT; Pancreatic islets; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; TOPIRAMATE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MOUSE; MOUSE STRAIN; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; RAT; RAT STRAIN; WEIGHT GAIN;

EID: 21444459072     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00403.x     Document Type: Article

References (20)

1. Shank RJ, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics and mechanism of action. Epilepsia 2000; 41: S3-S9.
2. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked currents in mouse brain neurons and increases seizure threshold. Epilepsy Res 2000; 28: 167-179.
3. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked currents in mouse brain neurons and increases seizure threshold. Epilepsy Res 1997; 28: 167-179.
4. Gibbs JW, Sombati S, DeLorenzo RJ, Coulter DA. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000; 41: S10-S16.
5. Zona C, Ciotti MT, Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells in culture. Neurosci Let 1997; 231: 123-126.
6. Zhang XL, Velumian A, Jones OT, Carlen PL. Modulation of high voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia 2000; 41: S52-S60.
7. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isozymes. Epilepsia 2000; 41: S35-S39.
8. Biton V, Montouris GD, Ritter F et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology 1999; 52: 1330-1337.
9. Chengappa KN, Chalasani L, Brar J, Parepally H, Houck P, Levine J. Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review. Clin Ther 2002; 24: 1576-1584.
10. Schuler-Springorum M, Hebebrand J, Wehmeier PM, Remschmidt H. Is topiramate effective for weight loss in neuroleptic-induced obesity? 2 case reports. Z Kinder Jugendpsychiatr Psychother 2002; 30: 51-58.
11. Roy Chengappa KN, Levine J, Rathore D, Parepally H, Atzert R. Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. Eur Psychiatry 2001; 16: 186-190.
12. Picard F, Deshaies Y, Lalonde J, Samson P, Richard D. Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats. Obes Res 2000; 8: 656-663.
13. Wilkes J, Olefsky J. Effects of topiramate on insulin sensitivity in female ZDF rats. Diabetes 2003; 52: A138.
14. Corsetti JP, Sparks JD, Peterson RG, Smith RL, Sparks CE. Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis 2000; 148: 231-241.
15. Schneider P, Biko J, Schlamp D et al. Comparison of total and regional body composition in adolescent patients with anorexia nervosa and pair-matched controls. Eat Weight Disord 1998; 3: 179-187.
16. Richard D, Ferland J, Lalonde J, Samson P, Deshaies Y. Influence of topiramate in the regulation of energy balance. Nutrition 2000; 16: 961-966.
17. Picard F, Deshaies Y, Lalonde J, Samson P, Richard D. Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats. Obes Res 2000; 8: 656-663.
18. Janssen SW, Hermus AR, Lange WP et al. Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats. Exp Clin Endocrinol Diabetes 2001; 109: 273-282.
19. Herberg L, Leiter EH. Obesity/diabetes in mice with mutations in the leptin or leptin receptor genes. In: Frontiers in Animal Diabetes Research Sima A, Shafrir E eds. Harwood, The Netherlands: Academic Publishers, 2001: p63-p108.
20. Bertrand G, Gross R, Puech R, Loubatieres-Mariani MM, Bockaert J. Evidence for a glutamate receptor of the AMPA subtype which mediates insulin release from rat perfused pancreas. Br J Pharmacol 1992; 106: 354-359.